Related Experiment Video

Updated: Apr 2, 2026

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

36.1K

INPP4B is an oncogenic regulator in human colon cancer

S T Guo1, M N Chi2, R H Yang1

  • 1Department of Molecular Biology, Shanxi Cancer Hospital and Institute, Affiliated Hospital of Shanxi Medical University, Shanxi, China.

Oncogene
|September 29, 2015
PubMed

Insights

Inositol polyphosphate 4-phosphatase type II (INPP4B) is upregulated in colon cancer, driving proliferation by activating Akt and SGK3. Silencing INPP4B inhibits tumor growth, suggesting it as a therapeutic target for colon cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Inositol polyphosphate 4-phosphatase type II (INPP4B) typically acts as a tumor suppressor by inhibiting phosphatidylinositol 3-kinase (PI3K) signaling.
  • However, INPP4B is frequently overexpressed in human colon cancer cells, contradicting its known tumor-suppressive role.

Purpose of the Study:

  • To investigate the functional role of INPP4B in colon cancer development and progression.
  • To elucidate the molecular mechanisms by which INPP4B influences colon cancer cell signaling and growth.

Main Methods:

  • Gene silencing (siRNA) and overexpression techniques were used to manipulate INPP4B levels in colon cancer cells.
  • Western blotting and cell proliferation assays were employed to assess the impact on signaling pathways (Akt, SGK3) and cellular growth.
  • Xenograft models were utilized to evaluate the effect of INPP4B on tumor growth in vivo.
  • Protein phosphatase activity assays and transcriptional analysis (Ets-1) were performed to understand the underlying mechanisms.

Main Results:

  • Silencing INPP4B suppressed colon cancer cell proliferation and xenograft tumor growth by blocking Akt and SGK3 activation.
  • Overexpression of INPP4B promoted proliferation and anchorage-independent growth in normal colon epithelial cells.
  • INPP4B's effects on Akt and SGK3 were linked to the inactivation of the phosphatase and tensin homolog (PTEN) via its protein phosphatase activity.
  • Ets-1 mediated the transcriptional upregulation of INPP4B in colon cancer cells.

Conclusions:

  • INPP4B functions as an oncogenic driver in colon cancer, promoting cell proliferation and tumor growth.
  • The mechanism involves INPP4B-mediated PTEN inactivation, leading to enhanced Akt and SGK3 signaling.
  • Targeting INPP4B presents a potential novel therapeutic strategy for colon cancer treatment.

More Related Videos

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy05:21

Real-time Imaging of Myeloid Cells Dynamics in ApcMin/+ Intestinal Tumors by Spinning Disk Confocal Microscopy

Published on: October 6, 2014

10.2K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.1K